Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.97%24.11B | -9.26%94.56B | -8.15%24.34B | -8.52%23.59B | -10.50%23.43B | -9.89%23.19B | 18.31%104.21B | 16.43%26.5B | 11.34%25.79B | 26.32%26.18B |
Cost of revenue | 0.90%17.11B | -5.40%69.76B | -13.28%17.68B | -3.29%17.61B | -2.70%17.51B | -1.09%16.96B | 18.95%73.74B | 23.38%20.39B | 16.45%18.21B | 22.75%18B |
Gross profit | 12.35%7.01B | -18.61%24.8B | 8.95%6.66B | -21.09%5.98B | -27.63%5.92B | -27.44%6.24B | 16.78%30.47B | -2.02%6.11B | 0.73%7.58B | 34.94%8.18B |
Operating expense | 7.78%3.7B | -4.06%14.3B | -16.40%3.77B | -1.55%3.3B | 5.57%3.81B | -0.46%3.43B | 8.93%14.91B | 22.58%4.51B | -0.83%3.35B | 5.31%3.61B |
Operating profit | 17.92%3.31B | -32.56%10.49B | 80.07%2.89B | -36.58%2.68B | -53.83%2.11B | -45.50%2.81B | 25.44%15.56B | -37.31%1.61B | 2.00%4.23B | 73.44%4.57B |
Net non-operating interest income (expenses) | 32.00%-17M | 10.64%-84M | 18.92%-30M | -56.25%-25M | 82.61%-4M | -38.89%-25M | -20.51%-94M | -94.74%-37M | 15.79%-16M | -15.00%-23M |
Non-operating interest income | 266.67%11M | 33.33%20M | -60.00%2M | 100.00%8M | 75.00%7M | 50.00%3M | 50.00%15M | 66.67%5M | 300.00%4M | 0.00%4M |
Non-operating interest expense | 0.00%28M | -4.59%104M | -23.81%32M | 65.00%33M | -59.26%11M | 40.00%28M | 23.86%109M | 90.91%42M | 0.00%20M | 12.50%27M |
Net investment income | 21.46%781M | 14.11%1.2B | 692.86%333M | 114.17%18M | -39.22%203M | -19.63%643M | 33.46%1.05B | -76.92%42M | -141.91%-127M | 827.78%334M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 248.76%180M | 0 | -139.16%-121M | -121M | ||||||
Income from associates and other participating interests | 300.00%4M | 275.00%21M | 142.86%6M | 340.00%12M | -66.67%2M | 0.00%1M | -125.00%-12M | -240.00%-14M | -138.46%-5M | -14.29%6M |
Special income (charges) | 10.00%-36M | -3.68%-1.38B | 55.81%-491M | -2,167.65%-771M | 0.00%-80M | 62.96%-40M | -632.42%-1.33B | -361.00%-1.11B | -161.54%-34M | -100.00%-80M |
Less:Other special charges | -10.00%36M | 217.86%890M | 639.66%429M | 979.41%367M | -32.50%54M | -62.96%40M | 53.85%280M | -75.93%58M | 161.54%34M | 100.00%80M |
Less:Write off | ---- | -53.28%492M | -94.11%62M | --404M | ---- | ---- | --1.05B | --1.05B | --0 | ---- |
Other non-operating income (expenses) | -118.18%-14M | -0.82%966M | -33.06%563M | 148.72%97M | 487.18%229M | 40.00%77M | 685.48%974M | 1,068.06%841M | 254.55%39M | 14.71%39M |
Income before tax | 16.32%4.03B | -28.89%11.39B | 172.01%3.28B | -46.35%2.19B | -49.23%2.46B | -41.12%3.46B | 19.43%16.02B | -53.12%1.2B | -8.14%4.08B | 82.84%4.85B |
Income tax | 17.36%1.24B | -31.34%3.75B | -6.48%923M | -24.72%944M | -44.71%826M | -38.76%1.06B | 37.68%5.47B | 46.01%987M | -4.86%1.25B | 72.72%1.49B |
Net income | 15.86%2.78B | -27.63%7.64B | 978.44%2.35B | -55.94%1.25B | -51.21%1.64B | -42.11%2.4B | 11.77%10.55B | -88.47%218M | -9.56%2.83B | 87.74%3.36B |
Net income continuous operations | 15.86%2.78B | -27.62%7.64B | 983.87%2.35B | -55.94%1.25B | -51.24%1.64B | -42.10%2.4B | 11.76%10.55B | -88.53%217M | -9.53%2.83B | 87.74%3.36B |
Noncontrolling interests | 0.00%-1M | 33.33%-12M | 83.33%-3M | -6M | -2M | -1M | -18M | -18M | 0 | 0 |
Net income attributable to the company | 15.85%2.79B | -27.63%7.65B | 897.88%2.36B | -55.71%1.25B | -51.19%1.64B | -42.06%2.4B | 11.95%10.57B | -87.53%236M | -9.59%2.83B | 87.80%3.36B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 15.85%2.79B | -27.63%7.65B | 897.88%2.36B | -55.71%1.25B | -51.19%1.64B | -42.06%2.4B | 11.95%10.57B | -87.53%236M | -9.59%2.83B | 87.80%3.36B |
Gross dividend payment | ||||||||||
Basic earnings per share | 16.17%21.956 | -29.78%60.168 | 1,585.09%18.536 | -54.47%9.852 | -52.85%12.88 | -46.95%18.9 | 5.86%85.686 | -93.22%1.1 | -19.31%21.64 | 78.27%27.318 |
Diluted earnings per share | 16.17%21.956 | -29.78%60.168 | 1,585.09%18.536 | -54.48%9.8499 | -52.86%12.8768 | -40.89%18.9 | 17.85%85.686 | -92.45%1.1 | -10.16%21.64 | 98.56%27.318 |
Dividend per share | 0 | 0.00%18 | 0.00%9 | 0 | 0.00%9 | 0 | 12.50%18 | 0.00%9 | 0 | 28.57%9 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |